Business Context and Reporting Period
Creative Medical Technology Holdings, Inc. (Nevada) filed this Form 8-K on April 11, 2018, reporting events occurring on that date and April 12, 2018. The filing details a material definitive agreement involving the amendment and immediate conversion of promissory notes held by its parent company, Creative Medical Health, Inc. ("CMH").
Key Financial Metrics and Transaction Details
- Debt Converted: Total outstanding principal and accrued interest of $136,003.
- Original Notes: Three 8% promissory notes issued in 2016 with principal amounts of $50,000, $50,000, and $25,000.
- Conversion Price: 120% of the 30-day volume weighted average price (VWAP) of common stock from March 1, 2018, to March 30, 2018 ($0.0138).
- Equity Issued: 9,855,290 restricted shares of common stock issued to CMH.
- Liquidity Impact: The transaction eliminated $136,003 in debt obligations in exchange for equity, with no cash outflow.
Material Changes Versus Prior Period
The filing does not provide comparative financial statements or revenue/profit metrics for the current period versus prior periods. The primary material change is the reduction of debt on the balance sheet and the corresponding increase in outstanding share count due to the conversion of the CMH notes.
Guidance, Outlook, and Risks
The filing references a press release dated April 12, 2018, which may contain forward-looking statements. Management cautions that actual results could differ materially from anticipated results due to factors discussed in the Annual Report on Form 10-K for the year ended December 31, 2017. The company assumes no obligation to update these statements. The issuance of shares was made pursuant to Rule 506(b) of Regulation D as a transaction not involving a public offering, with no selling commissions paid.
Investor Verification Checklist
- Verify the impact of the 9,855,290 new shares on existing shareholder dilution.
- Confirm the current status of the company's debt load following the $136,003 conversion.
- Review the Form 10-K for the year ended December 31, 2017, for risk factors referenced in the forward-looking statements.
- Check the restricted status and trading limitations of the shares issued to CMH.